Vancouver, B.C. and Boston, MA, March 3, 2017 – Imagin Medical (CSE: IME) (OTC PINK: IMEXF) (Frankfurt/Stuttgart Stock Exchanges: DPD2) (the “Company”) announced today that it has closed the private...
Read More
Vancouver, B.C. and Boston, MA, February 24, 2017 – Imagin Medical (CSE: IME) (OTC PINK: IMEXF) (Frankfurt/Stuttgart Stock Exchanges: DPD2) (the “Company”) announced today that it will issue on a...
Read More
Vancouver, B.C. and Boston, MA, February 22, 2017 – Imagin Medical (CSE: IME) (OTC PINK: IMEXF) (Frankfurt/Stuttgart Stock Exchanges: DPD2) (the “Company”) announced today that it has executed a non-binding...
Read More
Blue Light Cystoscopy in Patients with Suspected Non-Muscle Invasive Bladder Carcinoma: A Review of Clinical Utility [Internet].
Tran K, Severn M.
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2017 Feb 15.
PMID: 28825777 Free Books & Documents. Review.
https://linkprotect.cudasvc.com/url?a=https%3a%2f%2fpubmed.ncbi.nlm.nih.gov%2f28825777%2f&c=E,1,OxXvuw2LyEwXw6BW3Hqpd6VZSWJHa4exUeq4sZEc0w9UEOnvq6DsUacIPSua_2p73L30sdhxjeaYbDSCe497JrY0-UDEsI4fSYsQIZ6iw3HKMcyiAroLUmHHrl4,&typo=1
Vancouver, B.C. and Boston, MA, February 9, 2017 – Imagin Medical (CSE: IME) (OTC PINK: IMEXF) (Frankfurt/Stuttgart Stock Exchanges: DPD2) (the “Company”) announced today that the i/Blue Imaging System technology...
Read More
Vancouver, B.C. and Boston, MA, March 2, 2017 – Imagin Medical (CSE: IME) (OTC PINK: IMEXF) (Frankfurt/Stuttgart Stock Exchanges: DPD2) (the “Company”) announced today that the Company and Optel, Inc.,...
Read More
Vancouver, B.C. and Boston, MA, January 10, 2017 – Imagin Medical (CSE: IME) (OTC PINK: IMEXF) (Frankfurt/Stuttgart Stock Exchanges: DPD2) (the “Company”) announced today that, during 2016, the Company laid...
Read More
